Cosmax Inc (192820 KO) stock market data APIs
₩168241.7386
700(0.4%)
as of December 18, 2025
Try our APIs with
free plan!
Cosmax Inc Financial Data Overview
Price chart is built with
Anychart
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.
Prev. Close
168241.7386
Open
168884.5266
High
170082.8874
Low
163956.2963
52 wk Range
140100-287000
Market Cap
1 916 282 M
Shares Outstanding
11 346 K
Revenue
2 355 754 M
EPS
789
Dividends (Yield)
0.0135
Beta
1.045
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cosmax Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cosmax Inc data using free add-ons & libraries
Get Cosmax Inc Fundamental Data
Cosmax Inc Fundamental data includes:
- Net Revenue: 2 355 754 M
- EBITDA: 261 342 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: 3268.51
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cosmax Inc News
New
COSMAX Established OTC Lab…'Targeting the $2.6 Billion U.S. sun care market'
- Actively responding to its global clients targeting the U.S. sun care market - Strengthening the K-Sunscreen formulations lineup including cushions and sticks - Enhancing its expertise in sun care...
COSMAX Introduces 'Capsule Sun,' a Sunscreen Formula without Emulsifiers
- A white-cast-free formulation with high-spreadability - Applied COSMAX's patent technology, 'Clear Fence' - Plans to continuously introduce new sun care formulas to fulfill customers' various need...
Cosmax Develops AI-based Standard for Measuring Cosmetic Texture
- Objective texture data from 3-year research will be applied to develop new basic products using AI. - Expectation of paradigm shift in the industry including customized cosmetics sector. SEONGNAM,...
COSMAX Group Expands Business to Pet Care...Targeting $200B Market
Started operations of pet supplements manufacturing plant Produces 'human-grade' products with differentiated ingredients Plans to expand pet care business from supplements to cosmetics SEONGNAM, Sou...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
